BEAM Alliance

The race against time continues: we are still seeing initiatives to support innovation emerge (see below), whilst at the same time the ecosystem continues to shrink… The post BEAM Alliance Newsletter #8-2026 appeared first on BEAM Alliance.

Read the full paper to explore why patient benefit, rather than a winner-takes-all approach, should remain at the heart of antimicrobial innovation policy. The post Patients need more than one antimicrobial option appeared first on BEAM Alliance.

SNIPR001 is a CRISPR-armed phage therapeutic designed to selectively target E. coli in the gut, with the aim of preventing infections from spreading into the bloodstream. The post SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding

Invasive fungal infections pose a critical threat for children suffering from hematologic malignancies or immunodeficiency disorders. The post Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba

This funding round marks a critical step in Vaxdyn's evolution into a clinical-stage company, allowing us to clinically validate a promising vaccine platform designed to combat antimicrobial resistance

The AMR conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. The post

This designation underscores the significant unmet medical need for new treatment options for patients suffering from serious infections caused by multidrug-resistant Acinetobacter baumannii and supports our efforts to bring BV100 to patients as efficient

This webinar will be particularly relevant for innovators looking to prepare early for upcoming European opportunities and strengthen future collaborative submissions. The post BEAM Alliance Webinar: Advancing AMR Innovation through European Funding, Part

With heatwaves becoming more frequent, evidence is growing on their impact on pathogens, healthcare systems and antimicrobial resistance-yet governments may still need reminding of these risks. The post BEAM Alliance Newsletter #7-2026 appeared first on B

Webinar on the antimicrobial R&D talent shortage, its causes, and innovative solutions to attract and retain researchers. The post REVIVE Webinar: Breaking the resistance: Empowering the next generation of antimicrobial researchers appeared first on BEAM